A multicenter prospective study to evaluate the utility of animal naming test for the diagnosis of covert hepatic encephalopathy
Not Applicable
Recruiting
- Conditions
- iver cirrhosis
- Registration Number
- JPRN-UMIN000046313
- Lead Sponsor
- Department of Gastroenterology/Internal medicine, Gifu University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients with previous shunt operation or transjunglar intrahepatic portosystemic shunt 2.Patients with infection 3.Patients with overt hepatic encephalopathy, gastrointestinal bleeding, and spontaneous bacterial peritonitis within 4 weeks 4.Patient with alcohol abuse (60 g/day or more) within 4 weeks 5.Patients with neuromuscular disease which affect the results of the neuropsychological test 6.Patients who receive medications for dementia 7.Patients with severe comorbidities such as heart, renal, and respiratory failure 8.Patients who are inadequate for the study 9.Volunteers who are initially related to the study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The relationship between animal naming test and covert hepatic encephalopathy
- Secondary Outcome Measures
Name Time Method The relationship between animal naming test and each variable (sarcopenia, frailty, falls, fracture, traffic accident, quality of life). The relationship between animal naming test and clinical outcomes (overt hepatic encephalopathy and mortality).